Literature DB >> 14974911

Fine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma.

G Opocher1, F Schiavi, A Vettori, F Pampinella, L Vitiello, A Calderan, B Vianello, A Murgia, M Martella, A Taccaliti, F Mantero, M L Mostacciuolo.   

Abstract

OBJECTIVE: Despite the very recent discovery that about 25% of apparently sporadic forms of pheochromocytoma are actually due to germline mutations of RET, VHL, SDHB or SDHD genes, the genetic bases of the tumourigenesis of this type of cancer are still incompletely understood. Recent studies provided evidence that a new tumour suppressor gene, mapping on the short arm of chromosome 1, could be involved in early tumourigenesis of pheochromocytoma.
DESIGN: We have performed a fine analysis of loss of heterozygosity (LOH) of this region. In particular, we have analysed 31 highly polymorphic microsatellites distributed at 3.8 Mege base (Mb) mean intervals along the short arm of the chromosome 1 in paired samples of DNA extracted from peripheral blood lymphocytes and tumour tissues. PATIENTS: The study was carried out on 38 patients with pheochromocytoma that had been grouped, by careful clinical and molecular investigation, in the following classes: 21 sporadic, five multiple endocrine neoplasia type 2 (MEN2), two type 1 neurofibromatosis (NF1), five von Hippel-Lindau (VHL), one somatic VHL mutated and four nonsyndromic familial cases.
RESULTS: In 12/21 sporadic cases (57.1%), in 4/5 MEN2 (80%), 2/4 non-syndromic familial cases (50%), and in 2/2 NF1 (100%), the entire short arm was deleted, while in 6/21 sporadic (28.6%) and 1/5 MEN2 (20%) cases a partial deletion was detected. On the other hand, none of the five cases due to VHL mutation (either germline or somatic) had LOH at chromosome 1. In total, complete or partial deletion of 1p was detected in 27/38 (71%) of the cases. The most frequently deleted marker was D1S2890, which maps at 1p32.1. This region, which spans from 50 to 62 Mb from telomere, was therefore further investigated with markers located at a mean interval of 1.3 Mb in the subset of cases that showed a partial deletion of 1p. This analysis showed that a small region between 55.1 and 59.0 Mb was most frequently missing, which could therefore contain a novel pheochromocytoma locus.
CONCLUSIONS: The results presented here confirm that the short arm of chromosome 1 harbours one or more genes responsible for the development of pheochromocytoma and suggest that one of them could map in a 3.9-Mb fragment between 1p32.3 and 1p32.1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14974911     DOI: 10.1046/j.1365-2265.2003.01910.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.

Authors:  Giuseppe Opocher; Pierantonio Conton; Francesca Schiavi; Beatrice Macino; Franco Mantero
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 2.  Iodothyronine deiodinases and cancer.

Authors:  A Piekiełko-Witkowska; A Nauman
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

3.  Lack of association between microsatellite instability and benign adrenal tumors.

Authors:  Fares Namour; Ahmet Ayav; Xiaohong Lu; Marc Klein; Miahela Muresan; Laurent Bresler; Denise Tramoy; Jean-Louis Guéant; Laurent Brunaud
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

4.  The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.

Authors:  Susanne Schlisio; Rajappa S Kenchappa; Liesbeth C W Vredeveld; Rani E George; Rodney Stewart; Heidi Greulich; Kristina Shahriari; Nguyen V Nguyen; Pascal Pigny; Patricia L Dahia; Scott L Pomeroy; John M Maris; A Thomas Look; Matthew Meyerson; Daniel S Peeper; Bruce D Carter; William G Kaelin
Journal:  Genes Dev       Date:  2008-03-11       Impact factor: 11.361

Review 5.  SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.

Authors:  B Pasini; C A Stratakis
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989

6.  Overexpression of ERBB-2 was more frequently detected in malignant than benign pheochromocytomas by multiplex ligation-dependent probe amplification and immunohistochemistry.

Authors:  WenQi Yuan; WeiQinq Wang; Bin Cui; TingWei Su; Yan Ge; Lei Jiang; WeiWei Zhou; Guang Ning
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

7.  ARHI is a novel epigenetic silenced tumor suppressor in sporadic pheochromocytoma.

Authors:  Dong Wang; Li Song; Liang Wang; Lianmei Zhao; Bai Xiang; Ying Li; Baoen Shan; Jing Liu
Journal:  Oncotarget       Date:  2017-09-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.